Biopsychosocial assessment tools for the elderly – Assessment summary sheet
Test: Fracture and Mortality (FRAMO) Index Year: 2007 Variations/translations: None known
Setting: Any setting of elderly persons.
Method of delivery: Interviewer asks questions, requires verbal responses. Questionnaire may also be filled out directly by the client. Description: The FRAMO index was developed as a clinical predictor of fracture and mortality risk in order to identify patients who may be candidates for more intensive preventative measures. It contains four simply worded questions with yes / no answers. The FRAMO index identified the majority of women experiencing hip fractures during the 2 year follow up study period. It was recently revalidated and correlated with portable heel bone mineral density (BMD) to further refine the high risk group category. Scoring/interpretation: Binary scoring system: score is 1 for yes and 0 for no. Scores of 0 to 1 deemed low risk and 2 to 4 indicate high risk for fracture.
Time
to administer: A
few
minutes. Availability: contact author, Daniel Albertsson: daniel.albertsson@ltkronoberg.se
Software: N/A
Website:
Qualitative/Quantitative: Quantitative Validity: Predictive validity: 81% sensitivity, 64% specificity for hip fracture risk; 81% sensitivity, 67% specificity for mortality. Reliability: Not known.
References: Albertsson, D. M., Mellstrom, D., Petersson, C., & Eggertson, R. (2007) Validation of a 4-item score predicting hip fracture and mortality risk among elderly women. Annals of Family Medicine, 5, 48-56. Albertsson, D. M., Mellstrom, D., Petersson, C., Thulesius, H. & Eggertson, R. (2010) Hip and fragility fracture prediction by 4-item clinical risk score and mobile heel BMD: a women cohort study. BMC Musculoskeletal Disorders, 11, 55. Retrieved from http://www.biomedcentral.com/1471-2474/11/55/abstract on March 24, 2010. Gill, S. (2007) The 4-item Fracture and Mortality Index predicted hip fracture and all cause mortality in elderly women. Evidence-Based Medicine, 12(4), 122. Comments: The FRAMO index was validated in white, rural, Swedish female populations. It has yet to be modified for males. Gill (2007) has advocated for further validation and study in other cohorts before wider application by clinicians. |